Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign

 
• By Cathy Kelly
Merck's PAH Drug Is Priced Well Above ICER-Recommended Range • Source: Shutterstock

More from Market Access

More from Pink Sheet